134 related articles for article (PubMed ID: 24793456)
21. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo.
Jang B; Park JY; Tung CH; Kim IH; Choi Y
ACS Nano; 2011 Feb; 5(2):1086-94. PubMed ID: 21244012
[TBL] [Abstract][Full Text] [Related]
22. A pH-responsive fluorescent probe and photosensitiser based on a self-quenched phthalocyanine dimer.
Ke MR; Ng DK; Lo PC
Chem Commun (Camb); 2012 Sep; 48(72):9065-7. PubMed ID: 22864462
[TBL] [Abstract][Full Text] [Related]
23. Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy.
Hu M; Brasseur N; Yildiz SZ; van Lier JE; Leznoff CC
J Med Chem; 1998 May; 41(11):1789-802. PubMed ID: 9599230
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and photodynamic activities of integrin-targeting silicon(IV) phthalocyanine-cRGD conjugates.
Zheng BY; Yang XQ; Zhao Y; Zheng QF; Ke MR; Lin T; Chen RX; Ho KKK; Kumar N; Huang JD
Eur J Med Chem; 2018 Jul; 155():24-33. PubMed ID: 29852329
[TBL] [Abstract][Full Text] [Related]
25. An acid-cleavable phthalocyanine tetramer as an activatable photosensitiser for photodynamic therapy.
Chow SY; Lo PC; Ng DK
Dalton Trans; 2016 Aug; 45(33):13021-4. PubMed ID: 27396392
[TBL] [Abstract][Full Text] [Related]
26. A fluorescence-activatable tumor-reporting probe for precise photodynamic therapy.
Li J; Wang T; Jiang F; Hong Z; Su X; Li S; Han S
J Mater Chem B; 2021 Jul; 9(29):5829-5836. PubMed ID: 34254096
[TBL] [Abstract][Full Text] [Related]
27. Highly water-soluble and tumor-targeted photosensitizers for photodynamic therapy.
Li Y; Wang J; Zhang X; Guo W; Li F; Yu M; Kong X; Wu W; Hong Z
Org Biomol Chem; 2015 Jul; 13(28):7681-94. PubMed ID: 26082999
[TBL] [Abstract][Full Text] [Related]
28. A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy.
Ke MR; Chen SF; Peng XH; Zheng QF; Zheng BY; Yeh CK; Huang JD
Eur J Med Chem; 2017 Feb; 127():200-209. PubMed ID: 28063352
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.
Schneider R; Schmitt F; Frochot C; Fort Y; Lourette N; Guillemin F; Müller JF; Barberi-Heyob M
Bioorg Med Chem; 2005 Apr; 13(8):2799-808. PubMed ID: 15781391
[TBL] [Abstract][Full Text] [Related]
30. The synthesis and applications of 5-aminolevulinic acid (ALA) derivatives in photodynamic therapy and photodiagnosis.
Dabrowski Z; Kwaśny M; Kamiński J; Bełdowicz M; Lewicka L; Obukowicz B; Kaliszewski M; Pirozyńska E
Acta Pol Pharm; 2003; 60(3):219-24. PubMed ID: 14556493
[TBL] [Abstract][Full Text] [Related]
31. Development of an Azo-Based Photosensitizer Activated under Mild Hypoxia for Photodynamic Therapy.
Piao W; Hanaoka K; Fujisawa T; Takeuchi S; Komatsu T; Ueno T; Terai T; Tahara T; Nagano T; Urano Y
J Am Chem Soc; 2017 Oct; 139(39):13713-13719. PubMed ID: 28872304
[TBL] [Abstract][Full Text] [Related]
32. A tumor mRNA-triggered photodynamic molecular beacon based on oligonucleotide hairpin control of singlet oxygen production.
Chen J; Lovell JF; Lo PC; Stefflova K; Niedre M; Wilson BC; Zheng G
Photochem Photobiol Sci; 2008 Jul; 7(7):775-81. PubMed ID: 18597024
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
Cauchon N; Ali H; Hasséssian HM; van Lier JE
Photochem Photobiol Sci; 2010 Mar; 9(3):331-41. PubMed ID: 20221459
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy: tumor targeting with adenoviral proteins.
Allen CM; Sharman WM; La Madeleine C; Weber JM; Langlois R; Ouellet R; van Lier JE
Photochem Photobiol; 1999 Oct; 70(4):512-23. PubMed ID: 10546549
[TBL] [Abstract][Full Text] [Related]
35. Photosensitizer (PS)-cyanine dye (CD) conjugates: Impact of the linkers joining the PS and CD moieties and their orientation in tumor-uptake and photodynamic therapy (PDT).
James NS; Joshi P; Ohulchanskyy TY; Chen Y; Tabaczynski W; Durrani F; Shibata M; Pandey RK
Eur J Med Chem; 2016 Oct; 122():770-785. PubMed ID: 27543778
[TBL] [Abstract][Full Text] [Related]
36. Induction of tumor necrosis by delta-aminolevulinic acid and 1,10-phenanthroline photodynamic therapy.
Rebeiz N; Arkins S; Rebeiz CA; Simon J; Zachary JF; Kelley KW
Cancer Res; 1996 Jan; 56(2):339-44. PubMed ID: 8542589
[TBL] [Abstract][Full Text] [Related]
37. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
38. An integrin-targeting glutathione-activated zinc(II) phthalocyanine for dual targeted photodynamic therapy.
Ha SYY; Wong RCH; Wong CTT; Ng DKP
Eur J Med Chem; 2019 Jul; 174():56-65. PubMed ID: 31029944
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic activity of BAM-SiPc, an unsymmetrical bisamino silicon(IV) phthalocyanine, in tumour-bearing nude mice.
Leung SC; Lo PC; Ng DK; Liu WK; Fung KP; Fong WP
Br J Pharmacol; 2008 May; 154(1):4-12. PubMed ID: 18332853
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
